JP2023539695A5 - - Google Patents
Info
- Publication number
- JP2023539695A5 JP2023539695A5 JP2023537724A JP2023537724A JP2023539695A5 JP 2023539695 A5 JP2023539695 A5 JP 2023539695A5 JP 2023537724 A JP2023537724 A JP 2023537724A JP 2023537724 A JP2023537724 A JP 2023537724A JP 2023539695 A5 JP2023539695 A5 JP 2023539695A5
- Authority
- JP
- Japan
- Prior art keywords
- acrylamide
- indazole
- alkyl
- alkylene
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2013731.1A GB202013731D0 (en) | 2020-09-01 | 2020-09-01 | Novel cmpounds |
| GB2013731.1 | 2020-09-01 | ||
| PCT/GB2021/052262 WO2022049377A1 (en) | 2020-09-01 | 2021-09-01 | Novel compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539695A JP2023539695A (ja) | 2023-09-15 |
| JP2023539695A5 true JP2023539695A5 (cg-RX-API-DMAC7.html) | 2024-09-11 |
| JP7784431B2 JP7784431B2 (ja) | 2025-12-11 |
Family
ID=72749727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537724A Active JP7784431B2 (ja) | 2020-09-01 | 2021-09-01 | 新規化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12497359B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208448B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7784431B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096712B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021336750A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3190786A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202013731D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300904A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022049377A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202013728D0 (en) | 2020-09-01 | 2020-10-14 | Nrg Therapeutics Ltd | Novel compounds |
| GB202300833D0 (en) | 2023-01-19 | 2023-03-08 | Nrg Therapeutics Ltd | Novel compounds |
| CN121866248A (zh) | 2023-09-05 | 2026-04-14 | Nrg治疗有限公司 | 作为mptp抑制剂起作用的吡啶衍生物 |
| CN118255724A (zh) * | 2024-03-27 | 2024-06-28 | 河北天成药业股份有限公司 | 盐酸利多卡因杂质的合成方法及其反应检测方法 |
| GB202410534D0 (en) | 2024-07-18 | 2024-09-04 | Nrg Therapeutics Ltd | Novel method and uses |
| CN120025281A (zh) * | 2025-04-22 | 2025-05-23 | 九洲药业(杭州)有限公司 | 一种n,n-二异丁基-1h-吲唑-4-胺的中间体及制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2003020313A1 (ja) | 2001-09-04 | 2004-12-16 | 小野薬品工業株式会社 | スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤 |
| AU2002354476A1 (en) | 2001-12-14 | 2003-06-30 | Japan Tobacco Inc. | Pyrazolopyridine derivatives and medicinal use thereof |
| JP2006512306A (ja) | 2002-08-29 | 2006-04-13 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途 |
| BRPI0619263A2 (pt) * | 2005-11-30 | 2011-09-27 | Hoffmann La Roche | indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis |
| JP5495206B2 (ja) | 2006-10-24 | 2014-05-21 | コンジエニア・ソシエタ・ア・レスポンサビリタ・リミタータ | 変性性組織障害をmptの阻害により防止するための薬剤としてのフェニル置換マレイミド |
| EP2179984A1 (en) * | 2008-10-27 | 2010-04-28 | Congenia S.r.l. | Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| WO2011087051A1 (ja) | 2010-01-14 | 2011-07-21 | 国立大学法人金沢大学 | S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬 |
| JP2017538676A (ja) | 2014-11-05 | 2017-12-28 | ザ ユニバーシティ オブ カンザス | ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤 |
| CA2884607A1 (en) | 2015-03-11 | 2016-09-11 | Stealth Peptides International, Inc. | Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions |
| WO2019002624A1 (de) | 2017-06-30 | 2019-01-03 | Kleuser, Burkhard | Mittel zur therapie entzündlicher darmerkrankungen |
| GB202013728D0 (en) * | 2020-09-01 | 2020-10-14 | Nrg Therapeutics Ltd | Novel compounds |
-
2020
- 2020-09-01 GB GBGB2013731.1A patent/GB202013731D0/en not_active Ceased
-
2021
- 2021-09-01 AU AU2021336750A patent/AU2021336750A1/en not_active Abandoned
- 2021-09-01 EP EP21769790.3A patent/EP4208448B1/en active Active
- 2021-09-01 CN CN202180053586.6A patent/CN116096712B/zh active Active
- 2021-09-01 WO PCT/GB2021/052262 patent/WO2022049377A1/en not_active Ceased
- 2021-09-01 CA CA3190786A patent/CA3190786A1/en active Pending
- 2021-09-01 IL IL300904A patent/IL300904A/en unknown
- 2021-09-01 US US18/023,488 patent/US12497359B2/en active Active
- 2021-09-01 JP JP2023537724A patent/JP7784431B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2538714T3 (es) | Derivados de 2,4,5-trifenil-imidazolina como inhibidores de la interacción entre las proteínas p53 y MDM2 para el uso en calidad de agentes anticancerosos | |
| ES2750655T3 (es) | Derivados de pirrolo[2,3-d]pirimidina útiles para inhibir la Janus cinasa | |
| ES2605565T3 (es) | Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina | |
| JP2023539694A5 (cg-RX-API-DMAC7.html) | ||
| PE20091444A1 (es) | Derivados de isoxazolo-pirazina | |
| HRP20201107T1 (hr) | Heteroaril amidi kao inhibitori proteinske agregacije | |
| JP2018115215A5 (cg-RX-API-DMAC7.html) | ||
| MA38272A1 (fr) | Peptides en tant qu'agonistes de l'oxytocine | |
| GEP20125621B (en) | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | |
| ES2733502T3 (es) | Compuestos de imidazopiridazina | |
| AR076376A1 (es) | Azetidinil diamidas como inhibidores de monoacilglicerol lipasa | |
| JP2012523440A5 (cg-RX-API-DMAC7.html) | ||
| HRP20160253T1 (hr) | Inhibitor benzodiazepinske bromodomene | |
| JP2013010792A5 (cg-RX-API-DMAC7.html) | ||
| JP2017524742A (ja) | テトラヒドロキノリン誘導体の調製のための合成中間体の調製方法 | |
| AU2013326850B2 (en) | Novel compounds, their preparation and their uses | |
| CA2971110A1 (en) | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis | |
| JP2019535825A5 (cg-RX-API-DMAC7.html) | ||
| CA2758474A1 (en) | Novel p2x7r antagonists and their use | |
| MA38079A1 (fr) | Composés de 2-phényl-5-hétérocyclyl-tétrahydro-2h-pyran-3-amine destinés à être utilisés dans le traitement du diabète et de ses troubles associés | |
| MA38323B1 (fr) | Dérivés pyrimidone et leur utilisation dans le traitement, l'amélioration ou la prévention d'une maladie virale | |
| AR051290A1 (es) | Derivados de hidantoina sustituidas | |
| RU2018103332A (ru) | Пиримидиновое соединение с конденсированными кольцами, его промежуточное соединение, способ получения, композиция и применение | |
| JP2023509944A5 (cg-RX-API-DMAC7.html) | ||
| JP2024534111A5 (cg-RX-API-DMAC7.html) |